CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Novartis Adr Repsg 1 - USD - NVS CFD

81.88
2.01%
0.12
Rendah: 81.88
Tinggi: 83.32
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.12
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Novartis AG ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

Key Stats
Prev. Close* 83.56
Open* 82.95
1-Year Change* -3.64%
Day's Range* 81.88 - 83.32
52 wk Range 74.09-94.26
Average Volume (10 days) 2.31M
Average Volume (3 months) 41.57M
Market Cap 188.52B
P/E Ratio 26.47
Shares Outstanding 2.12B
Revenue 51.74B
EPS 3.16
Dividend (Yield %) 4.18155
Beta 0.52
Next Earnings Date Apr 25, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 22, 2023 81.88 -0.98 -1.18% 82.86 83.35 81.62
Mar 21, 2023 83.56 -0.02 -0.02% 83.58 83.76 82.99
Mar 20, 2023 83.34 0.52 0.63% 82.82 83.40 82.43
Mar 17, 2023 82.14 -0.58 -0.70% 82.72 83.05 81.87
Mar 16, 2023 82.72 0.49 0.60% 82.23 82.85 81.75
Mar 15, 2023 82.04 0.82 1.01% 81.22 82.36 81.19
Mar 14, 2023 82.07 0.27 0.33% 81.80 82.12 81.16
Mar 13, 2023 81.58 0.22 0.27% 81.36 82.40 81.35
Mar 10, 2023 80.63 0.00 0.00% 80.63 81.13 80.16
Mar 9, 2023 79.99 -0.77 -0.95% 80.76 80.85 79.70
Mar 8, 2023 83.23 -0.43 -0.51% 83.66 83.85 82.99
Mar 7, 2023 83.94 -0.93 -1.10% 84.87 84.95 83.57
Mar 6, 2023 84.87 0.02 0.02% 84.85 85.59 84.50
Mar 3, 2023 84.63 0.18 0.21% 84.45 84.84 84.27
Mar 2, 2023 85.04 1.07 1.27% 83.97 85.21 83.58
Mar 1, 2023 83.76 -0.46 -0.55% 84.22 84.45 83.50
Feb 28, 2023 84.05 -1.02 -1.20% 85.07 85.15 83.66
Feb 27, 2023 85.44 -0.67 -0.78% 86.11 86.15 85.32
Feb 24, 2023 85.57 -0.72 -0.83% 86.29 86.30 85.27
Feb 23, 2023 86.50 0.01 0.01% 86.49 86.73 85.74

Novartis Adr Repsg 1 - USD Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 52877 49898 48624 46017 43361
Revenue 52877 49898 48624 46017 43361
Cost of Revenue, Total 15435 14400 13930 13555 13416
Gross Profit 37442 35498 34694 32462 29945
Total Operating Expense 41188 39746 39538 31824 34658
Selling/General/Admin. Expenses, Total 14815 14093 14319 13690 12468
Research & Development 9041 8484 8386 8154 7808
Depreciation / Amortization 109 64 50 179 187
Unusual Expense (Income) 1173 2503 2284 -4309 395
Other Operating Expenses, Total 653 538 607 549 384
Operating Income 11689 10152 9086 14193 8703
Interest Income (Expense), Net Non-Operating 14628 -146 -36 -5 418
Other, Net -180 -128 -110 -93 -19
Net Income Before Taxes 26137 9878 8940 14095 9102
Net Income After Taxes 24018 8071 7147 12800 7499
Minority Interest 3 1 -5 -3 0
Net Income Before Extra. Items 24021 8072 7142 12797 7499
Net Income 24021 8072 11732 12611 7703
Income Available to Common Excl. Extra. Items 24021 8072 7142 12797 7499
Income Available to Common Incl. Extra. Items 24021 8072 11732 12611 7703
Dilution Adjustment
Diluted Net Income 24021 8072 11732 12611 7703
Diluted Weighted Average Shares 2260 2296 2319 2344 2371
Diluted EPS Excluding Extraordinary Items 10.6288 3.51568 3.07978 5.45947 3.1628
Dividends per Share - Common Stock Primary Issue 3.19907 3.08737 2.83413 2.93645 2.71776
Diluted Normalized EPS 11.1183 4.40641 3.86715 3.79006 3.30006
Total Extraordinary Items 4590 -186 204
Interest Expense (Income) - Net Operating -38 -336 -38 6
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 12814 13522 13367 13294 12694
Revenue 12814 13522 13367 13294 12694
Cost of Revenue, Total 3755 4000 3848 3754 3833
Gross Profit 9059 9522 9519 9540 8861
Total Operating Expense 9962 10960 10134 9815 10279
Selling/General/Admin. Expenses, Total 3498 3984 3601 3710 3520
Research & Development 2256 2369 2261 2284 2127
Depreciation / Amortization 35 30 25 27 27
Interest Expense (Income) - Net Operating 102 12 -9 60 -101
Unusual Expense (Income) 193 307 312 -136 690
Other Operating Expenses, Total 123 258 96 116 183
Operating Income 2852 2562 3233 3479 2415
Interest Income (Expense), Net Non-Operating -203 14415 21 38 54
Other, Net 20 -26 -24 -11 -19
Net Income Before Taxes 2669 16951 3230 3506 2450
Net Income After Taxes 2219 16306 2758 2895 2059
Minority Interest 3 2 0 1 0
Net Income Before Extra. Items 2222 16308 2758 2896 2059
Net Income 2222 16308 2758 2896 2059
Income Available to Common Excl. Extra. Items 2222 16308 2758 2896 2059
Income Available to Common Incl. Extra. Items 2222 16308 2758 2896 2059
Diluted Net Income 2222 16308 2758 2896 2059
Diluted Weighted Average Shares 2237 2257 2254 2243 2265
Diluted EPS Excluding Extraordinary Items 0.99329 7.22552 1.2236 1.29113 0.90905
Dividends per Share - Common Stock Primary Issue 0 3.19907 0 0 0
Diluted Normalized EPS 1.06502 7.35637 1.3418 1.24106 1.16507
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 45718 29673 29504 35563 28208
Cash and Short Term Investments 28113 11293 11234 15718 9347
Cash 3396 3750 3247 3121 2970
Cash & Equivalents 9011 5908 7865 10150 5890
Short Term Investments 15706 1635 122 2447 487
Total Receivables, Net 9621 10036 10337 11036 11101
Accounts Receivable - Trade, Net 8005 8217 8301 8739 8601
Total Inventory 6666 7131 5982 6956 6867
Prepaid Expenses 1102 943 898 812 756
Other Current Assets, Total 216 270 1053 1041 137
Total Assets 131795 127778 118370 145563 133079
Property/Plant/Equipment, Total - Net 13106 13939 13746 15696 16464
Property/Plant/Equipment, Total - Gross 28708 29894 28676 34028 34010
Accumulated Depreciation, Total -15602 -15955 -14930 -18332 -17546
Goodwill, Net 29595 29999 26524 35294 31750
Intangibles, Net 34182 36809 28787 38719 29997
Long Term Investments 2268 11611 10538 9789 16645
Note Receivable - Long Term 973 922 624 908 968
Other Long Term Assets, Total 5953 4825 8647 9594 9047
Total Current Liabilities 30208 33059 28264 29607 23403
Accounts Payable 5553 5403 5424 5556 5169
Accrued Expenses 5100 5336 5058 5105 4811
Notes Payable/Short Term Debt 3606 7319 4844 6430 4842
Current Port. of LT Debt/Capital Leases 2896 2558 2248 3190 359
Other Current Liabilities, Total 13053 12443 10690 9326 8222
Total Liabilities 64140 71180 62896 66949 58911
Total Long Term Debt 24523 27978 22056 22470 23224
Long Term Debt 22902 26259 20353 22470 23224
Deferred Income Tax 3070 3141 5867 7475 5168
Minority Interest 167 68 77 78 59
Other Liabilities, Total 6172 6934 6632 7319 7057
Total Equity 67655 56598 55474 78614 74168
Common Stock 901 913 936 944 969
Retained Earnings (Accumulated Deficit) 70989 57157 59274 82191 77639
Treasury Stock - Common -48 -53 -80 -69 -100
Unrealized Gain (Loss) 206 386
Other Equity, Total -4187 -1419 -4656 -4658 -4726
Total Liabilities & Shareholders’ Equity 131795 127778 118370 145563 133079
Total Common Shares Outstanding 2234.94 2256.82 2265.01 2311.17 2317.46
Capital Lease Obligations 1621 1719 1703
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 37236 45718 26253 23808 22198
Cash and Short Term Investments 18814 28329 8162 5356 4077
Cash & Equivalents 13852 12407 7211 5117 3801
Short Term Investments 4962 15922 951 239 276
Total Receivables, Net 8678 8283 8632 8654 8481
Accounts Receivable - Trade, Net 8409 8005 8377 8400 8265
Total Inventory 6997 6666 6885 7111 6997
Other Current Assets, Total 2747 2440 2574 2687 2643
Total Assets 125218 131795 121209 124015 121752
Property/Plant/Equipment, Total - Net 12861 13106 13157 13344 13204
Goodwill, Net 29636 29595 29572 29766 29590
Intangibles, Net 34853 34182 33951 34818 35377
Long Term Investments 2906 3241 12347 12014 11628
Other Long Term Assets, Total 7726 5953 5929 10265 9755
Total Current Liabilities 29807 30208 29880 29633 30160
Accounts Payable 5083 5553 4665 4811 5040
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6902 6502 9528 9278 10400
Other Current Liabilities, Total 17822 18153 15687 15544 14720
Total Liabilities 63678 64140 64438 69973 71229
Total Long Term Debt 24373 24523 24715 26491 27399
Long Term Debt 22796 22902 23101 24828 25747
Capital Lease Obligations 1577 1621 1614 1663 1652
Deferred Income Tax 3384 3070 3349 7472 7393
Minority Interest 164 167 166 86 66
Other Liabilities, Total 5950 6172 6328 6291 6211
Total Equity 61540 67655 56771 54042 50523
Common Stock 901 901 901 913 913
Retained Earnings (Accumulated Deficit) 60699 66802 55917 53194 49670
Treasury Stock - Common -60 -48 -47 -65 -60
Total Liabilities & Shareholders’ Equity 125218 131795 121209 124015 121752
Total Common Shares Outstanding 2212.58 2234.94 2237.09 2236.74 2245.09
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 24018 8071 7147 12800 7499
Cash From Operating Activities 15071 13650 13625 14272 12621
Cash From Operating Activities 1807 2088 1852 1783 1460
Amortization 4306 4376 3974 3428 3276
Non-Cash Items -11714 3842 3369 -2315 1983
Cash Taxes Paid 2342 1833 1876 1506 1487
Cash Interest Paid 664 703 793 816 697
Changes in Working Capital -3346 -4727 -2717 -1424 -1597
Cash From Investing Activities 4208 -13182 -2226 -5591 -3119
Capital Expenditures -2971 -2585 -2257 -2648 -2294
Other Investing Cash Flow Items, Total 7179 -10597 31 -2943 -825
Cash From Financing Activities -16264 -2208 -13627 -4244 -7733
Financing Cash Flow Items 94 -199 3307 -119 -101
Total Cash Dividends Paid -7368 -6987 -6645 -6966 -6495
Issuance (Retirement) of Stock, Net -3004 -2094 -5332 -1336 -5238
Issuance (Retirement) of Debt, Net -5986 7072 -4957 4177 4101
Foreign Exchange Effects -266 286 69 -26 84
Net Change in Cash 2749 -1454 -2159 4411 1853
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 2219 24018 7712 4954 2059
Cash From Operating Activities 1649 15071 11187 6262 2130
Cash From Operating Activities 392 1807 1287 893 514
Amortization 1013 4306 3307 2248 1183
Non-Cash Items 918 -11714 1732 803 386
Cash Taxes Paid 633 2342 1459 1144 735
Cash Interest Paid 110 664 458 301 112
Changes in Working Capital -2893 -3346 -2851 -2636 -2012
Cash From Investing Activities 9365 4208 -355 877 780
Capital Expenditures -859 -2971 -1994 -1455 -858
Other Investing Cash Flow Items, Total 10224 7179 1639 2332 1638
Cash From Financing Activities -9528 -16264 -13013 -11479 -8540
Financing Cash Flow Items 22 94 87 77 -35
Total Cash Dividends Paid -7506 -7368 -7368 -7368 -7368
Issuance (Retirement) of Stock, Net -2448 -3004 -2856 -2572 -1892
Issuance (Retirement) of Debt, Net 404 -5986 -2876 -1616 755
Foreign Exchange Effects -41 -266 -266 -201 -227
Net Change in Cash 1445 2749 -2447 -4541 -5857
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Dodge & Cox Investment Advisor/Hedge Fund 0.979 20751372 -297285 2022-12-31 LOW
PRIMECAP Management Company Investment Advisor 0.8112 17194880 -258270 2022-12-31 LOW
Loomis, Sayles & Company, L.P. Investment Advisor/Hedge Fund 0.5164 10945998 -3983754 2022-12-31 LOW
Franklin Mutual Advisers, LLC Investment Advisor/Hedge Fund 0.3121 6615062 -495110 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.2828 5993485 -509706 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.229 4854407 -233195 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.2155 4568714 41253 2022-12-31 LOW
Arrowstreet Capital, Limited Partnership Investment Advisor/Hedge Fund 0.1947 4127082 2498355 2022-12-31 MED
Managed Account Advisors LLC Investment Advisor 0.1908 4043458 -1491223 2022-12-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 0.1856 3933293 594023 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.1663 3525896 170517 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1614 3420970 239100 2022-12-31 HIGH
Schafer Cullen Capital Management, Inc. Investment Advisor/Hedge Fund 0.1315 2787713 -679560 2022-12-31 LOW
Parametric Portfolio Associates LLC Investment Advisor 0.1249 2647981 -49658 2022-12-31 LOW
Principal Global Investors (Equity) Investment Advisor 0.1163 2466037 7806 2022-12-31 LOW
Northern Trust Global Investments Investment Advisor 0.1123 2379524 -95663 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.1075 2279635 -1267963 2022-12-31 HIGH
UBS Financial Services, Inc. Investment Advisor 0.0983 2082692 -258460 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0891 1888357 -38920 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.086 1822796 -161869 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Pharmaceuticals (NEC)

Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

70.43 Price
+0.490% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0050%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

BTC/USD

27,739.90 Price
+1.070% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

XRP/USD

0.45 Price
+5.840% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00461

Gold

1,977.13 Price
+0.330% 1D Chg, %
Biaya inap posisi Long -0.0086%
Biaya inap posisi short 0.0004%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda